Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (51-60 of 361) with videos related to

Pageof 37
Sort By:
Clinical Chemistry|March 28, 2025
A Meta-Analysis and Systematic Review of Cardiac Troponin I vs T in Community Dwelling Adults: Is Specificity at Risk?Yashika Parashar, Aya Awwad, Soahum Bagchi, et al.
International Journal of Nephrology and Renovascular Disease|May 16, 2018
Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trialLarry A Weinrauch, Brian Claggett, Jiankang Liu, et al.
Circulation|September 10, 2015
Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the ElderlyAmil M Shah, Brian Claggett, Aaron R Folsom, et al.
The Lancet. Diabetes & Endocrinology|April 18, 2018
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trialMilton Packer, Brian Claggett, Martin P Lefkowitz, et al.
Neuroimage|March 18, 2015
Distinct neural representations of placebo and nocebo effectsSonya Freeman, Rongjun Yu, Natalia Egorova, et al.
Journal of the American Heart Association|July 31, 2023
Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities StudyDiego Ramonfaur, Hicham Skali, Brian Claggett, et al.
JAMA Cardiology|January 25, 2018
Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities StudyAli Vazir, Brian Claggett, Susan Cheng, et al.
Circulation. Cardiovascular Imaging|February 5, 2016
Left Atrial Structure and Function Across the Spectrum of Cardiovascular Risk in the Elderly: The Atherosclerosis Risk in Communities StudyAlexandra Gonçalves, Chung-Lieh Hung, Brian Claggett, et al.
International Journal of Nephrology and Renovascular Disease|September 2, 2017
Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trialLarry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
Circulation|October 26, 2018
Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular DiseaseBrian Claggett, John M Lachin, Stefan Hantel, et al.
Pageof 37

Showing results (51-60 of 361) with videos related to

Sort By:
Pageof 37
Clinical Chemistry|March 28, 2025
A Meta-Analysis and Systematic Review of Cardiac Troponin I vs T in Community Dwelling Adults: Is Specificity at Risk?Yashika Parashar, Aya Awwad, Soahum Bagchi, et al.
International Journal of Nephrology and Renovascular Disease|May 16, 2018
Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trialLarry A Weinrauch, Brian Claggett, Jiankang Liu, et al.
Circulation|September 10, 2015
Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the ElderlyAmil M Shah, Brian Claggett, Aaron R Folsom, et al.
The Lancet. Diabetes & Endocrinology|April 18, 2018
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trialMilton Packer, Brian Claggett, Martin P Lefkowitz, et al.
Neuroimage|March 18, 2015
Distinct neural representations of placebo and nocebo effectsSonya Freeman, Rongjun Yu, Natalia Egorova, et al.
Journal of the American Heart Association|July 31, 2023
Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities StudyDiego Ramonfaur, Hicham Skali, Brian Claggett, et al.
JAMA Cardiology|January 25, 2018
Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities StudyAli Vazir, Brian Claggett, Susan Cheng, et al.
Circulation. Cardiovascular Imaging|February 5, 2016
Left Atrial Structure and Function Across the Spectrum of Cardiovascular Risk in the Elderly: The Atherosclerosis Risk in Communities StudyAlexandra Gonçalves, Chung-Lieh Hung, Brian Claggett, et al.
International Journal of Nephrology and Renovascular Disease|September 2, 2017
Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trialLarry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
Circulation|October 26, 2018
Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular DiseaseBrian Claggett, John M Lachin, Stefan Hantel, et al.
Pageof 37